摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2(R)-N-(tert-butoxycarbonyl)-N'-methoxy-N'-methylphenylglycinamide | 819796-91-3

中文名称
——
中文别名
——
英文名称
2(R)-N-(tert-butoxycarbonyl)-N'-methoxy-N'-methylphenylglycinamide
英文别名
(R)-N-Boc-N'-methyl-N'-methoxy-2-phenylglycinamide;tert-butyl N-[(1R)-2-[methoxy(methyl)amino]-2-oxo-1-phenylethyl]carbamate
2(R)-N-(tert-butoxycarbonyl)-N'-methoxy-N'-methylphenylglycinamide化学式
CAS
819796-91-3
化学式
C15H22N2O4
mdl
——
分子量
294.351
InChiKey
YSHFHFQXCUVLDX-GFCCVEGCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.125±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    21
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    67.9
  • 氢给体数:
    1
  • 氢受体数:
    4

SDS

SDS:dbb52d47f8e885a4d89236afccd4f355
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2(R)-N-(tert-butoxycarbonyl)-N'-methoxy-N'-methylphenylglycinamide苯甲醚间氯过氧苯甲酸三氟乙酸 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 2.0h, 生成 (R)-2-methyl-N-(2-oxo-1,2-diphenylethyl)propane-2-sulfonamide
    参考文献:
    名称:
    Stille Coupling of Stereochemically Defined α-Sulfonamidoorganostannanes
    摘要:
    Addition of tributylstannylmetallics to (R)-tert-butanesulfonimine derivatives of arylaldehydes provides alpha-sulfinamidostannanes with high (>98% de) diastereoselectivities. Oxidation of these compounds with m-CPBA gives alpha-sulfonamidostannanes which undergo Pd/Cu-catalyzed Stille-type couplings with benzoyl chloride. Best yields are achieved using the electron-rich tris(2,4,6-trimethoxyphenyl)phosphine as the ligand. Inversion of configuration at the benzylic carbon is observed.
    DOI:
    10.1021/ja044354s
  • 作为产物:
    描述:
    左旋苯甘氨酸 在 sodium carbonate 、 1-羟基苯并三唑 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下, 以 1,4-二氧六环二氯甲烷 为溶剂, 生成 2(R)-N-(tert-butoxycarbonyl)-N'-methoxy-N'-methylphenylglycinamide
    参考文献:
    名称:
    Stille Coupling of Stereochemically Defined α-Sulfonamidoorganostannanes
    摘要:
    Addition of tributylstannylmetallics to (R)-tert-butanesulfonimine derivatives of arylaldehydes provides alpha-sulfinamidostannanes with high (>98% de) diastereoselectivities. Oxidation of these compounds with m-CPBA gives alpha-sulfonamidostannanes which undergo Pd/Cu-catalyzed Stille-type couplings with benzoyl chloride. Best yields are achieved using the electron-rich tris(2,4,6-trimethoxyphenyl)phosphine as the ligand. Inversion of configuration at the benzylic carbon is observed.
    DOI:
    10.1021/ja044354s
点击查看最新优质反应信息

文献信息

  • COMPOUNDS HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY
    申请人:Sakagami Masahiro
    公开号:US20110028468A1
    公开(公告)日:2011-02-03
    This invention provides a compound of the formula (I): a pharmaceutically acceptable salt or solvate thereof, wherein R 1 is substituted or unsubstituted alkyl or the like, R 2 is hydrogen or substituted or unsubstituted alkyl, Ring A is monocyclic or bicyclic aromatic heterocycle, R 3 is substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted heterocycle, R 4 is halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl or the like, m is an integer between 0 and 2, n is an integer between 0 and 5, R is halogen, oxo, cyano, nitro, substituted or unsubstituted alkyl or the like, and p is an integer between 0 and 2 as novel compounds having NPY Y5 antagonistic activity.
    这项发明提供了式(I)的化合物: 其药学上可接受的盐或溶剂化合物, 其中 R1为取代或未取代的烷基或类似物, R2为氢或取代或未取代的烷基, 环A为单环或双环芳香杂环, R3为取代或未取代的芳基,取代或未取代的杂芳基或取代或未取代的杂环, R4为卤素,氰基,取代或未取代的烷基,取代或未取代的环烷基或类似物, m为0到2之间的整数, n为0到5之间的整数, R为卤素,氧代,氰基,硝基,取代或未取代的烷基或类似物,以及 p为0到2之间的整数 作为具有NPY Y5拮抗活性的新化合物。
  • Preparation of α-Hydroxy-β-Fmoc Amino Acids from N-Boc Amino Acids
    作者:Christopher Teleha、Erik Johnson、M. Hubieki、Andrew Combs
    DOI:10.1055/s-0031-1289586
    日期:2011.12
    A general method for the conversion of N-Boc amino acids­ into their homologated α-hydroxy-β-Fmoc amino acids is described. The protocol involved preparation of the amino aldehyde by reduction of the corresponding Weinreb amides, hydrocyanation, and hydrolysis of the nitrile group, followed by reprotection of the amino acid as the Fmoc derivative. N-Boc amino acid - reduction - hydrocyanation - N-Fmoc
    描述了将N -Boc氨基酸转化为其同源的α-羟基-β-Fmoc氨基酸的一般方法。该方案涉及通过还原相应的Weinreb酰胺,氢氰化和腈基水解来制备氨基醛,然后将氨基酸作为Fmoc衍生物重新保护。 N -Boc氨基酸-还原-氢氰化-N -Fmoc氨基酸
  • 10.1016/j.ejmech.2024.116639
    作者:Zhang, Lei、Ke, Di、Li, Yuting、Zhang, Hui、Zhang, Xi、Wang, Sihan、Ni, Shaokai、Peng, Bo、Zeng, Huixuan、Hou, Tingjun、Du, Yushen、Pan, Peichen、Yu, Yongping、Chen, Wenteng
    DOI:10.1016/j.ejmech.2024.116639
    日期:——
    Moreover, (R, S)-16s demonstrated a potent anti-IAV efficacy (EC50 = 0.134 ± 0.093 μM) and weak cytotoxicity (CC50 = 15.35 μM), indicating the high selectivity of (R, S)-16s. Although the lead compound (R, S)-16s exhibited a little weaker activity than baloxavir, these findings illustrated the utility of a metal coordination-based strategy in generating novel MBPs with potent anti-influenza activity.
    由于流感病毒 RNA 聚合酶亚基 PAN 是一种双核 Mn2+ 依赖性核酸内切酶,因此具有 Mn2+ 配位的金属结合药效团 (MBP) 已被阐明为开发用于流感治疗的 PAN 抑制剂的一种有前途的策略。然而,很少有人关注 MBP 中供体原子的最佳排列与抗甲型流感病毒 (IAV) 疗效之间的关系。鉴于此,设计并合成了融合具有不同侧链、手性中心或环状系统的七元内酰胺环的特权羟基吡啶酮。构效关系研究产生命中化合物 16l (IC50 = 2.868 ± 0.063 μM对抗 IAV 聚合酶),其七元内酰胺环融合一个吡咯烷环。进一步优化 16l 上的疏水结合基团得到了先导化合物 (R, S)-16s,其对 IAV 聚合酶的抑制活性提高了 64 倍 (IC50 = 0.045 ± 0.002 μM)。此外,(R, S)-16s 表现出有效的抗 IAV 功效 (EC50 = 0.134 ± 0.093 μM)
  • Practical Synthesis of Fluorous Oxazolidinone Chiral Auxiliaries from α-Amino Acids
    作者:Jason E. Hein、Laina M. Geary、Ashley A. Jaworski、Philip G. Hultin
    DOI:10.1021/jo051696n
    日期:2005.11.1
    A series of new fluorous-supported oxazolidinone chiral auxiliaries has been prepared using a versatile and general five-step pathway, starting from readily available chiral a-amino acids. The key feature of this synthesis is the efficient generation of a suitably active perfluoroalkyllithium species. By use of this protocol, the auxiliaries can be obtained in high enantiomeric purity and on multigram scales from L-phenylalanine and L-valine with overall yields as high as 55%. The new methodology also incorporates fluorous solid-phase extraction on the large scale, allowing bulk quantities (up to 25 g) of fluorous compounds to be purified from the crude reaction mixture.
  • EP2280000
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物